SCHEMBL12258490

SCHEMBL12258490

CC(=O)Nc1ccc(/C=N/Nc2cccc(C(=O)O)c2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 1/20 0.73
NPC1 O15118 17/20 0.70
RAB9A P51151 17/20 0.70
GAA P10253 12/20 0.70
SMN1; SMN2 Q16637 11/20 0.70
MAPT P10636 10/20 0.70
KMT2A Q03164 9/20 0.70
MEN1 O00255 8/20 0.70
NFKB1 P19838 6/20 0.70
NFKB2 Q00653 6/20 0.70
RELA Q04206 6/20 0.70
ALDH1A1 P00352 4/20 0.70
KDM4E B2RXH2 2/20 0.70
POLB P06746 5/20 0.70
TDP1 Q9NUW8 3/20 0.70
L3MBTL1 Q9Y468 2/20 0.70
MCL1 Q07820 2/20 0.70
KLF5 Q13887 1/20 0.70
NSD2 O96028 1/20 0.70
RECQL P46063 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12258440 0.83 NPC1 (0.76) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL13187328 0.83 RAB9A (0.76) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL12581545 0.82 NPC1 (0.75) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL26935144 0.82 MAPT (0.72) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL12258152 0.82 NPC1 (1.00) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL29859752 0.82 MAPT (0.72) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL26915293 0.82 MAPT (0.72) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL12258442 0.81 NPC1 (0.76) NOX1NPC1RAB9AGAASMN1; SMN2
SCHEMBL13187334 0.81 NPC1 (0.72) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL13187300 0.80 NPC1 (0.70) NPC1RAB9AGAASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110263540-A1 SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2011-10-27 US disclosed
WO-2010053606-A9 SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2010-09-02 WO disclosed
WO-2010053606-A2 SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2010-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263540-A1 SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS MRPS27, MRPS22, MRPS23 NOX1 3905/4885NPC1 4228/4885RAB9A 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.